Drug information for NIMODIPINE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
30MG
Prescription
AB
NIMODIPINE
Nimodipine
BANNER PHARMACAPS
76740
2012-01-27 Review
2010-08-09 Other Important Information from FDA
CAPSULE; ORAL
30MG
Prescription
AB (Reference Drug)
NIMODIPINE
Nimodipine
SUN PHARM INDS INC
77067
2010-08-09 Other Important Information from FDA
2007-04-25 Letter
CAPSULE; ORAL
30MG
Prescription
AB
NIMODIPINE
Nimodipine
BARR LABS INC
77811
2010-08-09 Other Important Information from FDA
Drug Adverse Effects information for NIMODIPINE
Role code
Indications
Reaction
# Reports
C
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE
HEART RATE ABNORMAL
2
C
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE
SYNCOPE
2
C
DEMENTIA
HEART RATE ABNORMAL
2
C
DEMENTIA
SYNCOPE
2
C
HYPERLIPIDAEMIA
BLOOD CREATINE PHOSPHOKINASE INCREASED
1
C
HYPERLIPIDAEMIA
HYPOTHYROIDISM
1
C
HYPERTENSION
ACUTE MYOCARDIAL INFARCTION
2
C
HYPERTENSION
HEART RATE ABNORMAL
2
C
HYPERTENSION
RESPIRATORY ARREST
1
C
HYPERTENSION
SYNCOPE
2
C
HYPERTENSION
THROMBOCYTOPENIA
2
C
MULTIPLE MYELOMA
ACUTE MYOCARDIAL INFARCTION
2
C
MULTIPLE MYELOMA
THROMBOCYTOPENIA
2
C
OSTEOPOROSIS
AORTIC ANEURYSM
1
C
OSTEOPOROSIS
COLITIS
1
C
OSTEOPOROSIS
CORONARY ARTERY DISEASE
1
C
OSTEOPOROSIS
DISCOMFORT
1
C
OSTEOPOROSIS
HYPERTENSION
1
C
OSTEOPOROSIS
PAIN IN EXTREMITY
1
C
PARKINSON'S DISEASE
HEART RATE ABNORMAL
2
C
PARKINSON'S DISEASE
SYNCOPE
2
C
RELAPSING-REMITTING MULTIPLE SCLEROSIS
DYSARTHRIA
1
C
RELAPSING-REMITTING MULTIPLE SCLEROSIS
DYSPHAGIA
1
C
RELAPSING-REMITTING MULTIPLE SCLEROSIS
MULTIPLE SCLEROSIS RELAPSE
1
C
RELAPSING-REMITTING MULTIPLE SCLEROSIS
TRANSIENT ISCHAEMIC ATTACK
1
Ads by Google